For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
How does the forecasted CAGR of the obsessive-compulsive disorder industry compare to other sectors?
The obsessive-compulsive disorder market size has grown strongly in recent years. It will grow from $0.62 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 8.64%. The growth in the historic period can be attributed to a rise in early diagnosis, increasing prevalence of mental health, growth in the use of cognitive behavioral therapy, growth in access to online therapy, and growth in personalized treatment plans.
The obsessive-compulsive disorder market size is expected to see strong growth in the next few years. It will grow to $0.93 billion in 2029 at a compound annual growth rate (CAGR) of 8.38%. The growth in the forecast period can be attributed to rising prevalence of OCD, rising demand for off-label drugs and therapies, rising healthcare sector investment, increasing awareness campaigns, and rising government initiatives. Major trends in the forecast period include technological advancements, integration of digital health tools, integration of virtual reality, telehealth, and adoption of cognitive behavioral therapy.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20907&type=smp
What market trends are acting as primary growth drivers for the obsessive-compulsive disorder sector?
The increase in prevalence of mental illness is expected to propel the growth of the obsessive-compulsive disorder market going forward. Mental illness refers to a wide range of mental health conditions that affect mood, thinking, behavior, and overall functioning. Mental illness is increasing due to a combination of heightened awareness and diagnosis, lifestyle changes, chronic stress, global crises, and growing social, economic, and environmental pressures. Obsessive-compulsive disorder sheds light on the intricate mechanisms of mental illness, helping to advance understanding, diagnosis, and treatment approaches for broader mental health conditions. For instance, in September 2024, according to the reports published by The National Institutes of Health (NIH), a US-based government agency, in 2022, 59.3 million U.S. adults, representing 23.1% of the population, experienced AMI (Any Mental Illness), with a higher prevalence observed among females at 26.4% compared to 19.7% among males. Therefore, the increase in the prevalence of mental illness is driving the growth of the obsessive-compulsive disorder market.
What are the fastest-growing segments in the obsessive-compulsive disorder market forecast period?
The obsessive-compulsive disorder market covered in this report is segmented –
1) By Drug Class: Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Tricyclic Obsessive Compulsive Disorder
2) By Indication: Major Depressive Disorder, Anxiety Disorders, Attention Deficit Hyperactivity Disorder
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
4) By End-Users: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Selective Serotonin Reuptake Inhibitors (SSRIs): Fluoxetine, Sertraline, Paroxetine, Escitalopram
2) By Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Duloxetine, Venlafaxine
3) By Monoamine Oxidase Inhibitors (MAOIs): Moclobemide, Phenelzine
4) By Serotonin Antagonist And Reuptake Inhibitors (SARI): Trazodone, Nefazodone
5) By Tricyclic Obsessive Compulsive Disorder: Clomipramine, Amitriptyline
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/obsessive-compulsive-disorder-global-market-report
What evolving trends are creating new opportunities in the obsessive-compulsive disorder market?
Major companies operating in the obsessive-compulsive disorder market are focusing on mental health treatment to develop more effective therapeutic solutions. Mental health treatment refers to various therapies and interventions designed to manage and alleviate mental health conditions, including medications, counseling, and lifestyle changes. For instance, in October 2023, Newport Healthcare, a US-based healthcare company, introduced Newport Healthcare’s Obsessive-Compulsive Disorder Treatment Program, now open to teens and young adults. This initiative is uniquely tailored to address the specific developmental and psychological needs of young individuals grappling with OCD and related disorders. Leveraging a nationwide network, the program ensures accessibility to evidence-based therapies, including Cognitive Behavioral Therapy (CBT), Exposure and Response Prevention (ERP), and family-focused interventions. With a holistic care model, it integrates mental health treatment with mindfulness, physical wellness, and life skills development to foster comprehensive recovery.
Which major players hold significant market share in the obsessive-compulsive disorder sector?
Major companies operating in the obsessive-compulsive disorder market are Pfizer Inc., Merck & Co. Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Zydus Cadila, Amneal Pharmaceuticals Inc., Mallinckrodt plc, Lupin Pharmaceuticals Inc., Par Pharmaceutical, Biohaven Pharmaceuticals
Which regional segments are forecasted to witness the fastest growth in the obsessive-compulsive disorder market?
North America was the largest region in the obsessive-compulsive disorder market in 2024. The regions covered in the obsessive-compulsive disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Obsessive-Compulsive Disorder Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20907
Need Customized Data On Obsessive-Compulsive Disorder Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20907&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
